Given the established clinical use of GLP-1RAs for the treatment of T2DM, preclinical and clinical research was centered largely around DR, which suggested the neuropathologic protective effects of GLP-1 are due to downregulation of NF-B, proinflammatory cytokines such as TNF-alpha and IL-1beta, and VEGF
Comparing Benefits Sermorelin: Shorter half-life
Regular movement improves sleep quality, enhances mood, and supports metabolic health
This treatment is not suitable for individuals who are pregnant/breastfeeding, or those with pacemakers, heart conditions, active thrombosis, diabetes, epilepsy, auto-immune conditions, or active skin infections (psoriasis/eczema) in the treatment area
This is non-negotiable based on current evidence
Monitor Progress: Regular check-ups will help monitor your response to the treatment